Brian D. Edwards
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations.
Journal: Drug safety
Published: April 28, 2024
A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry.
Journal: Therapeutic innovation & regulatory science
Published: November 13, 2023
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Journal: Drug safety
Published: March 01, 2023
An Update on the International Society of Pharmacovigilance China Chapter.
Journal: Drug safety
Published: May 30, 2022
Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety.
Journal: Drug safety
Published: December 23, 2021
Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance.
Journal: Therapeutic advances in drug safety
Published: May 13, 2021
The Road to Pharmacovigilance Outsourcing Guidance.
Journal: Therapeutic innovation & regulatory science
Published: July 21, 2020
Human factors: the pharmaceutical supply chain as a complex sociotechnical system.
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: April 30, 2020
Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
Journal: British journal of clinical pharmacology
Published: April 15, 2020
Impact of causal uncertainty on rechallenge after dress syndrome has occurred.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: May 13, 2019
An Assessment of Concerns Regarding New Regulatory Guidance for Combination Products: A Review of the Submissions Made to the FDA Regarding Their Proposed Draft New Guidance on Human Factors Studies for a Combination Product in an Abbreviated New Drug Application.
Journal: Therapeutic innovation & regulatory science
Published: May 29, 2018
Last Updated: 09/26/2026